drugset / Trial / NCT06062680
Study of the Food Effects of Herombopag Olamine Tablets in Healthy Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
This study used a single-center, randomized, open-label, three-period, crossover trial design. Fifteen healthy subjects were planned to be enrolled, and the subjects were randomly assigned to any group A, B and C in the order of screening, with 5 cases in each group
Timeline
- Start
- 2023-10
- Primary completion
- 2023-11-15
- Completion
- 2023-11-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Herombopag Olamine | Unknown | 7.5 mg | — |